India's Growing Pharmaceutical Company

About Us

RT X GEN Pharmaceutical Pvt. Ltd. is a successful division of RT Group of Companies established in the year 2019. Under the guidance of our Chairman,Mr. Suresh Yadav. We tremendously progressed and earned a spot in leading Ayurveda and Pharmaceutical company in Pune, India. Our company deals in Pharma marketing and Pharma manufacturing for multiple ALLOPATHY, AYURVEDIC, NUTRACEUTICALS, MEDICAL EQUIPMENTS and HEALTH & WELLNESS. With systematically organized contract manufacturing process that addresses the manufacture of high-quality products, we have captured the niche market segment in a very low time. A dedicated team that focuses on key international markets has leveraged our expertise in the manufacture of APIs and formulations to market various products successfully across the globe.

KEY TRENDS
Pharmaceutical Export from India (US$ billion)

India is the world largest provider of generic medicines; the country’s generic drugs account for 20% of global generic drug exports (in terms of volumes). Indian drugs are exported to more than 200 countries in the world, with the U.S. as the key market.

Indian pharma companies ara capitalising on export oppurtunities in regulated and semi-regulated markets.

India’s public health expenditure has been steadily rising over the last decade in order to cater to its growing population. In fiscal year 2018, the value of public health expenditure by states and union territories together amounted to around 1.58 trillion Indian rupees. This was estimated to be around 1.28 % of the country’s GDP. In comparison, the United States’ budget estimates showed an outlay of over 17 % of the GDP to public health expenditure in its fiscal year 2018.

Govt. Expenditure on Health in India (US$ billion)

FY16

16.9%

FY17

16.8%

FY18

17.3%

FY19

19.1%

FY20

16.3%

FY21

17.6%